Abstract
Introduction: Deep brain stimulation improves motor symptoms in Parkinson's disease and changes primary motor cortex excitability, but how subthalamic nucleus stimulation affects premotor-motor cortical connectivity remains unclear. Methods: We investigated 10 Parkinson patients in whom single subthalamic nucleus stimulation was time-locked to transcranial magnetic dual-coil, paired-pulse stimulation of the dorsal premotor and primary motor cortex. Premotor-motor interaction with deep brain stimulation switched off was compared to 10 controls. Results: Parkinson patients showed abnormally facilitated premotor-motor interaction with deep brain stimulation switched off compared to controls. This abnormal premotor-motor facilitation was abolished during subthalamic nucleus stimulation at 3 Hz. Conclusions: In Parkinson's disease, aberrant signals from the basal ganglia leading to a loss of physiological premotor-motor inhibition can be normalized by subthalamic deep brain stimulation. This effect is likely mediated by activation of subthalamic-pallidal-thalamic projection to the premotor cortex.
| Original language | English |
|---|---|
| Journal | Parkinsonism and Related Disorders |
| Volume | 66 |
| Pages (from-to) | 224-227 |
| Number of pages | 4 |
| ISSN | 1353-8020 |
| DOIs | |
| Publication status | Published - 07.08.2019 |
Funding
This work was supported by a Canadian Institutes of Health Research Foundation Grant to Robert Chen ( FDN 154292 ) and the German Research Foundation and the Else Kröner-Fresenius Foundation to Anne Weissbach ( DFG WE5919/1-1 and 2018_A55 ) and to Alexander Münchau ( SFB 936/project C5 and FOR 2698 ). Appendix A Anne Weissbach received a scholarship from the German Research Foundation ( DFG , WE5919/1-1 ) and received funding from the University of Lübeck ( Habilitationsstipendium , H03-2016 ). She receives funding from the Else Kröner-Fresenius Foundation ( 2018_A55 ) and an Edmond J. Safra fellowship in movement disorders from the Michael J Fox foundation. Kaviraya Udupa reports no disclosures. Zhen Ni reports no disclosures. Carolyn Gunraj reports no disclosures. Cricia Rinchon received a graduate student award through Parkinson Society Canada. Julianne Baarbe received a doctoral award through Canadian Institutes in Health Research (# 357215 ). Alfonso Fasano has received grant support from the University of Toronto , the McLaughlin Centre and the Michael J. Fox Foundation ; he received speaking honoraria from UCB pharma, Medtronic, Boston Scientific, Brain Lab, Abbvie, Novartis, Chiesi pharmaceutical, Ipsen and TEVA; he is in an advisory board for Abbvie and Ipsen and provided consultancies for UCB pharma, Medtronic, Boston Scientific, and Abbvie. Renato P Munhoz reports no disclosures. Antony Lang has served as an advisor for Abbvie, Acorda, Avanir Pharmaceuticals, Biogen, Bristol Myers Squibb, Cipla, Intekrin, and Merck; received honoraria from Sun Pharma, Medichem, Medtronic, Teva, UCB, AbbVie and Sunovion; received grants from Brain Canada , Canadian Institutes of Health Research , Edmond J Safra Philanthropic Foundation , Michael J. Fox Foundation , the Ontario Brain Institute , National Parkinson Foundation , Parkinson Society Canada , and W. Garfield Weston Foundation ; received publishing royalties from Saunders, Wiley-Blackwell, Johns Hopkins Press, and Cambridge University Press. Vera Tadic report no disclosures. Norbert Brüggemann received a honorarium from Grünenthal. He has been funded by the DFG and the Collaborative Center for X-linked Dystonia-Parkinsonism . Alexander Münchau receives funding from the German Research Foundation ( DFG , SFB 936 , project C5 , FOR 2698 ). He receives grants and Honoraria for lectures from Pharm Allergan, Ipsen, Merz Pharmaceuticals, Actelion, GlaxoSmithKline and Desitin. Tobias Bäumer receives funding from the German Research Foundation ( FOR 2698 ). He receives Honoraria from Merz Pharmaceuticals, Allergan and Ipsen Pharma. He is a medical advisor to Merz Pharmaceuticals. Robert Chen was supported by a Canadian Institutes of Health Research Foundation Grant ( FDN 154292 ), Catherine Manson Chair in Movement Disorders , Dystonia Medical Research Foundation and Weston Brain Institute . He received honoraria from GE Healthcare, Merz and Allergan. All authors do not have any conflict of interest.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
-
SDG 10 Reduced Inequalities
Fingerprint
Dive into the research topics of 'Single-pulse subthalamic deep brain stimulation reduces premotor-motor facilitation in Parkinson's disease'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver